TY - JOUR
T1 - Diversifying the Mohs Workforce
T2 - Understanding Barriers of Applicants to Mohs Micrographic Surgery Fellowship
AU - Hoffman, Lauren
AU - Benesh, Gabrielle
AU - Soliman, Yssra
AU - Ciocon, David H.
AU - Williams, Ramone F.
N1 - Publisher Copyright:
© 2023 Journal of Drugs in Dermatology. All rights reserved.
PY - 2023/5
Y1 - 2023/5
N2 - Background: The population of the United States is becoming increasingly diverse, yet dermatology, especially Mohs micrographic surgery (MMS), lags behind. Objective: This survey study investigates perceived barriers of underrepresented groups in medicine (URM) who are pursuing fellowship in Mohs micrographic surgery and dermatologic oncology (MSDO). Methods and Materials: An IRB-approved survey was distributed electronically to accredited dermatology residencies between December 2020 and April 2021. Results: One hundred and thirty-three dermatology residents responded to the survey and of the participants, 21% identified as a URM. There was no significant difference in those interested in applying for MSDO fellowship between URMs and non-URMs. URMs rated the following factors significantly higher when deciding DotoNot pursue Copy MSDO fellowship: lack of perceived diversity in target patient population (mean 3.61, SD 1.66), race/ethnicity/gender Penalties of past MSDO Apply fellows (mean 3.25, SD 1.71), perceived attitudes of MSDO fellowships towards an applicant’s race or ethnicity (mean 3.25, 1.65 SD), and lack of diversity of trainees and faculty in MMS (mean 3.61, SD 1.47). Conclusion: This study is one of the first to evaluate perceived barriers to diversifying the MMS workforce. The perceived barriers we have identified are complex and require concerted efforts for improvement.
AB - Background: The population of the United States is becoming increasingly diverse, yet dermatology, especially Mohs micrographic surgery (MMS), lags behind. Objective: This survey study investigates perceived barriers of underrepresented groups in medicine (URM) who are pursuing fellowship in Mohs micrographic surgery and dermatologic oncology (MSDO). Methods and Materials: An IRB-approved survey was distributed electronically to accredited dermatology residencies between December 2020 and April 2021. Results: One hundred and thirty-three dermatology residents responded to the survey and of the participants, 21% identified as a URM. There was no significant difference in those interested in applying for MSDO fellowship between URMs and non-URMs. URMs rated the following factors significantly higher when deciding DotoNot pursue Copy MSDO fellowship: lack of perceived diversity in target patient population (mean 3.61, SD 1.66), race/ethnicity/gender Penalties of past MSDO Apply fellows (mean 3.25, SD 1.71), perceived attitudes of MSDO fellowships towards an applicant’s race or ethnicity (mean 3.25, 1.65 SD), and lack of diversity of trainees and faculty in MMS (mean 3.61, SD 1.47). Conclusion: This study is one of the first to evaluate perceived barriers to diversifying the MMS workforce. The perceived barriers we have identified are complex and require concerted efforts for improvement.
UR - http://www.scopus.com/inward/record.url?scp=85159548032&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85159548032&partnerID=8YFLogxK
U2 - 10.36849/JDD.7083
DO - 10.36849/JDD.7083
M3 - Article
C2 - 37133480
AN - SCOPUS:85159548032
SN - 1545-9616
VL - 22
SP - 471
EP - 474
JO - Journal of Drugs in Dermatology
JF - Journal of Drugs in Dermatology
IS - 5
ER -